India: Pfizer’s TM Suit Not Entertained: Lack Of Territorial Jurisdiction.

Last Updated: 10 March 2009

Jurisdiction being the most vital consideration while instituting a suit, the Lack of Jurisdiction is one of the first and vital contentions raised, as a ground for suits to be dismissed. The present matter of Pfizer Enterprises v. Dr. H.R. Manchanda 2009 (39) PTC 114 (Del.) dismissed Pfizer's plea with respect to the Delhi High Court's jurisdiction over the matter owing to lack of territorial jurisdiction. The suit deals with the infringement of a trademark as well as with passing off offence being committed by Dr. H.R. Manchanda, who averred the lack of jurisdiction in the present Court. Rendition of accounts and delivery up of goods was also prayed for by Pfizer.

Pfizer, a company organized under the laws of Luxembourg has its subsidiary, also party to the suit located in India since 1950. In addition to the large number of products available in the Indian market, 'Dalacin', a highly sought after antibiotic treats infections in different parts of the body caused by bacteria, which is the essential component of 'Dalacin C' and 'Dalacin T' is also marketed. It was stated that 'Dalacin C' was first adopted by the Upjohn Company in 1968 in India; (whose name was later changed to Pharmacia and Upjohn Company in 1996) and the mark later assigned to Pharmacia Enterprises SA in 2002, was subsequently renamed Pfizer Enterprises SARL, the first plaintiff.

The mark was averred to be fanciful and coined word with no denotative meaning being distinctive in nature. By virtue of priority in adoption, continuous and extensive use, and widespread advertisement, Pfizer was said to be the proprietor of the marks. However, both 'Dalacin C' and 'Dalacin T' are registered in India, Pfizer' subsidiary being the authorized user of the same. They aver that due to the extensive use and the reputation of Pfizer, the marks are exclusively identified with them.

'Clindamycin' the active ingredient in Dalacin is also manufactured by Pfizer's Indian subsidiary. Pfizer stated that they were shocked when they discovered from the website of the Defendants that they offered pharmaceutical compositions Clindamycin hydrochloride and Clindamycin phosphate under the mark 'Dalcinex', in capsule as well as injections form, just as Pfizer did. Pfizer alleged that use of the mark Dalcinex amounted to infringement and their attempt to dishonestly appropriate the goodwill amounted to passing off. The marks being phonetically and visually similar and put to use in relation to an identical product and therefore, would cause confusion in the minds of the public

Pfizer on the question of jurisdiction submitted that by virtue of Section 134(1) of the Trade Marks Act, 1999 Pfizer' and Dr. Manchanda' products being available for sale in Delhi. Dr. Manchanda and his co-parties however averred that none of the plaintiffs were registered proprietors of the trademarks within the meaning of section 2(i)(v) of the Act and hence no suit for infringement was maintainable. They also alleged the assignment deeds to be invalid and unreliable and that the registration of the mark Dalcinex which is pending since their year of manufacture 2004.

On the question of jurisdiction, Dr. Manchanda' counsel contended that the suit was not maintainable in this Court, since both the parties carried on business outside the jurisdiction of the Delhi High Court. It was further stated that no documentary evidence to support the availability of the product within the jurisdiction of this Court had been submitted. He also drew the attention of this Court to the fact that Pfizer had not averred or produced any document as to how Dr. Manchanda' product including the packaging has been procured in Delhi. It was submitted that the suit ought to be filed either in the place where the defendant resides and carries on business or the place at which the cause of action arises.

As regards the invalidity of the assignment deed, the same was said to be insufficiently stamped and invalid under section 45 of the 1999 Act. It was also submitted that copies of the certificates of renewal of trademark from the year 1982 did not bear the name of the proprietor on them. Pfizer was also stated to have insufficiently established the ingredients for an action of passing off. The Counsel also submitted that the mark had been coined using the alphabets of the generic salt, or ingredient and that no exclusive right could be asserted.

The Counsel contended that the sale of Dr. Manchanda' goods is something that cannot be denied. And that it was inconceivable that no business took place within the jurisdiction of this Court. The counsel for Pfizer relied upon the documents filed and submitted that the defendants are marketing their products and advertising through the Internet. It was submitted that the website can be accessed from Delhi and thus, this Court possesses jurisdiction. The Court stated that they needed to go through the contents of the plaint to decide whether the suit discloses a triable cause of action, and whether this court had jurisdiction or not.

The Court took into consideration Section 20 of the Code of Civil Procedure, 1908, Section 62(2) of the Copyright Act, 1957 and section 134 of the Trade Marks Act, 1999, for the adjudication of trademark disputes. They noted that the plaint showed that both the Indian Subsidiary of Pfizer and co-defendant had r offices in Mumbai and undeniably carry on their business in Mumbai too. However the plaint did not disclose either of them having their office in Delhi.

The Court noted that Pfizer was far from establishing neither that the defendants carried out the essential parts of their business from Delhi nor that their goods were in fact sold in Delhi. And that the allegation, therefore, that Pfizer has become aware of the infringing activities of the defendant, within territorial jurisdiction of this court, or that any cause of action arose within jurisdiction, are not even prima facie substantiated. Further, the Court stated that there is no purposeful direction of the web activities to the concerned geographical locale, in this case Delhi, to prima facie establish this Court's jurisdiction. The plaint was returned on account of clear lack of territorial jurisdiction.

© Lex Orbis 2009

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions